Con't From Jan '06
| Quote: |
Anonymous wrote:
Guest,
Thanks for finding that. I see that you did not offer an answer to HH on his question.
To my best knowledge, reformulating the topical and granting FDA approval are two separate issues for the time being. The topical needs to be reworked and the trial needs to begin another testing phase to gather information in order to apply to the FDA for approval.
Right now the timeline hinges on the ability of the researchers to get the formula down pat. This could take an additional year + depending on the manpower supplied and the possiblity of CRIS/DNA already having a decent backup plan in place. If they have no backup formula in mind, the timeline stretches further out. |
Thanks,
So if the Hh inhibitor is really not working because of the cream formula then curis/dna would be set back about a year plus. That seems reasonable. By that time I’m thinking Genentech will file an IND for solid tumors.
